BlackRock Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $6.11M | Buy |
242,062
+43,559
| +22% | +$1.1M | 0.01% | 1456 |
|
|
2016
Q3 | $4.91M | Buy |
198,503
+9,023
| +5% | +$223K | 0.01% | 1492 |
|
|
2016
Q2 | $3.86M | Buy |
189,480
+50,190
| +36% | +$1.02M | ﹤0.01% | 1617 |
|
|
2016
Q1 | $2.12M | Sell |
139,290
-9,648
| -6% | -$147K | ﹤0.01% | 1955 |
|
|
2015
Q4 | $2M | Buy |
148,938
+12,670
| +9% | +$170K | ﹤0.01% | 2082 |
|
|
2015
Q3 | $1.91M | Sell |
136,268
-971
| -0.7% | -$13.6K | ﹤0.01% | 2103 |
|
|
2015
Q2 | $2.33M | Buy |
137,239
+51,769
| +61% | +$879K | ﹤0.01% | 2108 |
|
|
2015
Q1 | $1.03M | Buy |
85,470
+539
| +0.6% | +$6.51K | ﹤0.01% | 2496 |
|
|
2014
Q4 | $705K | Sell |
84,931
-713
| -0.8% | -$5.92K | ﹤0.01% | 2788 |
|
|
2014
Q3 | $744K | Buy |
85,644
+1,368
| +2% | +$11.9K | ﹤0.01% | 2705 |
|
|
2014
Q2 | $923K | Buy |
84,276
+29,831
| +55% | +$327K | ﹤0.01% | 2653 |
|
|
2014
Q1 | $487K | Buy |
54,445
+10,420
| +24% | +$93.2K | ﹤0.01% | 2945 |
|
|
2013
Q4 | $332K | Buy |
44,025
+1,694
| +4% | +$12.8K | ﹤0.01% | 3114 |
|
|
2013
Q3 | $310K | Buy |
42,331
+3,022
| +8% | +$22.1K | ﹤0.01% | 3090 |
|
|
2013
Q2 | $253K | Buy |
+39,309
| New | +$253K | ﹤0.01% | 3114 |
|